OncoPharm cover image

NAPOLI 3, POUT, & Ivosidenib - Azole DDIs

OncoPharm

00:00

Clinical recommendations for managing the DDI

John recommends monitoring azole levels, considering dose adjustments, and notes no QT concerns observed in the study.

Play episode from 13:45
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app